Markets

Varian Ties Up to Initiate Access to Care Program in Africa

Varian Medical Systems, Inc.VAR recently announced an alliance with two universities in Cape Town for the rollout of Africa's first Access to Care program. The program is primarily intended to train caregivers in providing advanced conformal radiotherapy treatment to cancer patients.

The three-month training program will help departments implement and continue 3D conformal radiation therapy treatment programs at the hospitals. Notably, Access to Care will be offering two courses a year in South Africa. Varian offers similar programs in Vietnam and plans to start the same in Algeria as well.

We believe that such training programs will help better Africa's healthcare infrastructure and also aid the continent's fight against cancer.

According to WHO estimates, there will be approximately 1.6 million new cancer cases in Africa every year through 2030, resulting in 1.2 million deaths. However, the continent is in dire need of adept radiotherapy systems. According to a study published in Lancet Oncology, only 23 out of 52 African countries have radiotherapy available for patients.

A scenario as bleak as this presents ample opportunity for a company like Varian, which, on its part, is trying all means to expand its footprint in Africa.

Meanwhile, Varian has already installed over 100 radiotherapy systems in Africa over the last 25 years. The company recently announced a number of projects in Algeria, Egypt, South Africa, Ghana, Angola, Kenya and Madagascar. In 2014, Varian won a contract from the Algerian Ministry of Health to install advanced radiotherapy and radiosurgery systems in six centers. In March this year, the company opened a local unit in Algeria.

We believe that the newly announced Access to Care program will help Varian gain market traction in the continent.

Zacks Rank & Key Picks

Currently, Varian carries a Zacks Rank #3 (Hold). Better-ranked stocks in the medical sector include Masimo MASI , NuVasive NUVA and Thoratec THOR . All the stocks sport a Zacks Rank #1(Strong Buy).

Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days . Click to get this free report >>

Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report

VARIAN MEDICAL (VAR): Free Stock Analysis Report

THORATEC CORP (THOR): Free Stock Analysis Report

MASIMO CORP (MASI): Free Stock Analysis Report

NUVASIVE INC (NUVA): Free Stock Analysis Report

To read this article on Zacks.com click here.

Zacks Investment Research

The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.


The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.

In This Story

NUVA MASI VAR

Other Topics

Stocks

Latest Markets Videos